![Leo Groenewegen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Leo Groenewegen
Amministratore Delegato presso
NBAB, Nordic BioAnalysis AB
Health Technology
Profilo
Leo Groenewegen is currently the Chief Executive Officer at NBAB, Nordic BioAnalysis AB. Prior to this, he worked as the Chief Financial Officer at NextCell Pharma AB.
Posizioni attive di Leo Groenewegen
| Società | Posizione | Inizio |
|---|---|---|
NBAB, Nordic BioAnalysis AB
 NBAB, Nordic BioAnalysis AB BiotechnologyHealth Technology Engages in bio analytical development, validation and analysis of medicines | Amministratore Delegato | 01/09/2022 |
Precedenti posizioni note di Leo Groenewegen
| Società | Posizione | Fine |
|---|---|---|
| NEXTCELL PHARMA AB | Direttore Finanziario/CFO | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
NextCell Pharma AB
 NextCell Pharma AB Pharmaceuticals: MajorHealth Technology Develops investigational medicinal products | Health Technology |
NBAB, Nordic BioAnalysis AB
NBAB, Nordic BioAnalysis AB BiotechnologyHealth Technology Engages in bio analytical development, validation and analysis of medicines | Health Technology |
